Logo

OGT Will Use Integrated Genomics' P. pastoris Sequence to Develop Microarray

Mar 06, 2007
NEW YORK (GenomeWeb News) — Oxford Gene Technology will use a gene sequence from the Pichia pastoris yeast owned by Integrated Genomics to develop a new microarray, the firms said today.
 
Under the agreement, OGT will use the sequence to design and build a 60-mer microarray that uses OGT’s ink-jet synthesis platform.
 
OGT will market the array worldwide and offer sample analysis services at its UK lab.
 
P. pastoris is a methylotrophic yeast commonly used in recombinant DNA and protein expression projects.
 
Financial terms of the agreement were not released.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.